Global Carotid Stent Market 2015-2019

頸動脈ステントの世界市場2015-2019

◆タイトル:Global Carotid Stent Market 2015-2019
◆商品コード:IRTNTR6466
◆調査・発行会社:Technavio (Infiniti Research Ltd.)
◆発行日:2015年7月8日
◆ページ数:93
◆資料形式:pdf / 英語
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD2,500 ⇒換算¥277,500見積依頼/購入/質問フォーム
Five UserUSD3,000 ⇒換算¥333,000見積依頼/購入/質問フォーム
Enterprise License(全社内共有可)USD4,000 ⇒換算¥444,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、資料に記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はTechnavio (Infiniti Research Ltd.)の日本における正規販売代理店です。

【資料の概要】

当調査レポートでは、頸動脈ステントの世界市場について調査・分析し、エグゼクティブサマリー、市場概観、業界の構造分析、頸動脈ステントの世界市場規模及び予測、地域別分析、医療費償還シナリオ、購買基準、市場成長要因、市場の課題、市場動向、競争状況、主要企業(ベンダー)分析などの情報をお届けいたします。

About Carotid Stent
Carotid artery disease refers to the blockage or narrowing of carotid arteries due to plaque formation (Fibrous tissue, cholesterol, and calcium deposits. The carotid arteries are present in the neck and supply blood to the brain. Carotid artery stenting is a minimally invasive surgical procedure used to treat carotid artery disease. The technique involves the insertion of a slender metal-mesh tube (carotid stent) through a small incision. The carotid stent expands inside a carotid artery to increase blood flow in areas blocked by plaque. Globally, 90% of carotid surgeries are performed by vascular surgeons.

Technavio’s analysts forecast the global carotid stent market to grow at a CAGR of 13.17% over the period 2014-2019.

[Covered in this Report]
The report includes the present scenario and the growth prospects of the global carotid stent market for the period 2015-2019. To calculate the market size, Technavio uses revenue generated from sales of carotid stents.

Technavio’s report, Global Carotid Stent Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, APAC, and EMEA; it also covers the landscape of the global carotid stent market and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.

[Key Regions]
• Americas
• EMEA
• APAC

[Key Vendors]
• Abbott Vascular
• Boston Scientific
• Cordis (Johnson & Johnson)
• Medtronic

Other Prominent Vendor
• ev3
• Gore Medical
• InspireMD
• Optimed
• Terumo

[Market Driver]
• High Proportion of Elderly Population
• For a full, detailed list, view our report

[Market Challenge]
• Complications of Carotid Artery Stenting
• For a full, detailed list, view our report

[Market Trend]
• Rise in Number of Clinical Trials
• For a full, detailed list, view our report

[Key Questions Answered in this Report]
• What will the market size be in 2019 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?

【資料の目次】

01. Executive Summary

02.List of Abbreviations

03.Scope of the Report
03.1 Market Overview
03.2 Product Offerings

04.Market Research Methodology
04.1 Market Research Process
04.2 Research Methodology

05.Introduction

06.Market Landscape
06.1 Market Overview
06.2 Market Size and Forecast
06.3 Five Forces Analysis

07.Carotid Artery Stenosis: An Overview
07.1 Background
07.2 Carotid Artery Stenosis
07.2.1 Risk Factors for Carotid Artery Stenosis
07.2.2 Symptoms of Carotid Artery Stenosis
07.3 Treatment Options for Carotid Artery Stenosis
07.3.1 Treatment Recommendation for Symptomatic Carotid Artery Stenosis
07.3.2 Treatment Recommendation for Asymptomatic Carotid Artery Stenosis

08.Carotid Artery Stenting

09.Global Reimbursement Scenario
09.1 Reimbursement Scenario in US
09.1.1 Medicare Reimbursement Policy
09.1.2 Private Insurance Policy
09.1.3 ICD-9-CM Diagnosis Codes and Payments for Carotid Artery Procedures
09.2 Reimbursement Scenario in Other Major Countries
09.2.1 UK
09.2.2 Germany
09.2.3 Spain
09.2.4 Italy
09.2.5 France
09.2.6 Japan

10.Geographical Segmentation
10.1 Global Carotid Stent Market by Geography 2014-2019
10.2 Carotid Stent Market in Americas
10.2.1 Market Size and Forecast
10.3 Carotid Stent Market in EMEA
10.3.1 Market Size and Forecast
10.4 Carotid Stent Market in APAC
10.4.1 Market Size and Forecast

11.Buying Criteria

12.Market Growth Drivers

13.Drivers and their Impact

14.Market Challenges

15.Impact of Drivers and Challenges

16.Market Trends

17.Trends and their Impact

18.Vendor Landscape
18.1 Competitive Scenario
18.1.1 Key News
18.1.2 Mergers and Acquisitions
18.2 Major Vendor Analysis 2014
18.3 Other Prominent Vendors

19.Key Vendor Analysis
19.1 Abbott Laboratories
19.1.1 Key Facts
19.1.2 Business Description
19.1.3 Business Segmentation
19.1.4 Business Strategy
19.1.5 Revenue by Business Segmentation
19.1.6 Revenue Comparison 2011 and 2012
19.1.7 Revenue by Geographical Segmentation
19.1.8 Key Information
19.1.9 SWOT Analysis
19.2 Boston Scientific
19.2.1 Key Facts
19.2.2 Business Overview
19.2.3 Key Products
19.2.4 Key Products in Cardiovascular Segment
19.2.5 Key Products in MedSurg Segment
19.2.6 Key Products in Rhythm Management Segment
19.2.7 Business Segmentation by Revenue 2013
19.2.8 Business Segmentation by Revenue 2012 and 2013
19.2.9 Geographical Segmentation by Revenue 2013
19.2.10 Business Strategy
19.2.11 Recent Developments
19.2.12 SWOT Analysis
19.3 Cordis
19.3.1 Key Facts
19.3.2 Business Overview
19.3.3 Business Segmentation
19.3.4 Business Strategy
19.3.5 Recent Developments
19.3.6 SWOT Analysis
19.4 Medtronic
19.4.1 Key Facts
19.4.2 Business Overview
19.4.3 Key Products
19.4.4 Business Segmentation by Revenue 2014
19.4.5 Cardiac and Vascular Group Segmentation by Revenue 2014
19.4.6 Restorative Therapies Group Segmentation by Revenue 2014
19.4.7 Diabetes Group Segmentation by Revenue 2014
19.4.8 Business Segmentation by Revenue 2013 and 2014
19.4.9 Cardiac and Vascular Group Segmentation by Revenue 2013 and 2014
19.4.10 Restorative Therapies Group Segmentation by Revenue 2013 and 2014
19.4.11 Diabetes Group Segmentation by Revenue 2013 and 2014
19.4.12 Geographical Segmentation by Revenue 2014
19.4.13 Business Strategy
19.4.14 Key Developments
19.4.15 SWOT Analysis

20.Other Reports in This Series

[List of Exhibits]

Exhibit 1: Market Research Methodology
Exhibit 2: Global Carotid Stent Market 2014-2019 ($ millions)
Exhibit 3: Management of Carotid Artery Stenosis
Exhibit 4: Steps in Carotid Artery Stenting
Exhibit 5: Various Access Sites for Stenting
Exhibit 6: Global Carotid Stent Market by Geography 2014
Exhibit 7: Carotid Stent Market in Americas 2014-2019 ($ millions)
Exhibit 8: Carotid Stent Market in EMEA 2014-2019 ($ millions)
Exhibit 9: Carotid Stent Market in APAC 2014-2019 ($ millions)
Exhibit 10: Global Carotid Stent Market by Geography 2014-2019 ($ millions)
Exhibit 11: Global Carotid Stent Market by Geography 2014-2019
Exhibit 12: Major Drivers of Global Carotid Stent Market
Exhibit 13: Percentage of Elderly Aged Above 65 in Different Regions and Countries 2012 and 2050
Exhibit 14: Global Incidence of CAD with Age
Exhibit 15: Major Challenges in Global Carotid Stent Market
Exhibit 16: Major Trends in Global Carotid Stent Market
Exhibit 17: Abbott Laboratories: Key Takeaways
Exhibit 18: Boston Scientific: Key Takeaways
Exhibit 19: Cordis: Key Takeaways
Exhibit 20: Medtronic: Key Takeaways
Exhibit 21: Abbott Laboratories: Business Segmentation
Exhibit 22: Abbott Laboratories: Revenue by Business Segmentation 2012
Exhibit 23: Abbott Laboratories: Revenue by Business Segmentation 2011 and 2012 ($ millions)
Exhibit 24: Abbott Laboratories: Revenue by Geographical Segmentation 2012
Exhibit 25: Boston Scientific: Key Products in Cardiovascular Segment
Exhibit 26: Boston Scientific: Key Products in MedSurg Segment
Exhibit 27: Boston Scientific: Key Products in Rhythm Management Segment
Exhibit 28: Boston Scientific: Business Segmentation by Revenue 2013
Exhibit 29: Boston Scientific: Business Segmentation by Revenue 2012 and 2013 ($ millions)
Exhibit 30: Boston Scientific: Geographical Segmentation by Revenue 2013
Exhibit 31: Cordis: Business Segmentation 2013
Exhibit 32: Medtronic: Key Products
Exhibit 33: Medtronic: Business Segmentation by Revenue 2014
Exhibit 34: Medtronic: Cardiac and Vascular Group Segmentation by Revenue 2014
Exhibit 35: Medtronic: Restorative Therapies Group Segmentation by Revenue 2014
Exhibit 36: Medtronic: Diabetes Group Segmentation by Revenue 2014
Exhibit 37: Medtronic: Business Segmentation by Revenue 2013 and 2014 ($ millions)
Exhibit 38: Medtronic: Cardiac and Vascular Group Segmentation by Revenue 2013 and 2014 ($ million)
Exhibit 39: Medtronic: Restorative Therapies Group Segmentation by Revenue 2013 and 2014 ($ millions)
Exhibit 40: Medtronic: Diabetes Group Segmentation by Revenue 2013 and 2014 ($ millions)
Exhibit 41: Medtronic: Geographical Segmentation by Revenue 2014



【掲載企業】

Abbott Vascular, Boston Scientific, Cordis (Johnson & Johnson), Medtronic, ev3, Gore Medical, InspireMD, Optimed, Terumo

【資料のキーワード】

頸動脈ステント、頸動脈ステント留置術、頸動脈疾患、治療、医療機器

【調査方法】

一次資料による調査(業界専門家、ベンダー、代理店、顧客等を対象にしたデプスインタビュー調査など)及び二次資料による調査(Technavio独自のプラットフォーム、産業書籍、企業報告書、ニュース記事、アナリストレポート、貿易協会、政府機関発行データなど)

★調査レポート[頸動脈ステントの世界市場2015-2019] (Global Carotid Stent Market 2015-2019 / IRTNTR6466)販売に関する免責事項
[頸動脈ステントの世界市場2015-2019] (Global Carotid Stent Market 2015-2019 / IRTNTR6466)についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆